Synovus Financial Corp Acquires 28 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Synovus Financial Corp raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,572 shares of the medical equipment provider’s stock after acquiring an additional 28 shares during the period. Synovus Financial Corp’s holdings in Intuitive Surgical were worth $1,264,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in ISRG. Continuum Advisory LLC raised its position in Intuitive Surgical by 14.7% in the second quarter. Continuum Advisory LLC now owns 375 shares of the medical equipment provider’s stock worth $167,000 after acquiring an additional 48 shares during the period. Commerzbank Aktiengesellschaft FI raised its position in shares of Intuitive Surgical by 6.1% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 1,774 shares of the medical equipment provider’s stock valued at $789,000 after purchasing an additional 102 shares during the period. KG&L Capital Management LLC grew its stake in Intuitive Surgical by 59.6% during the second quarter. KG&L Capital Management LLC now owns 1,181 shares of the medical equipment provider’s stock valued at $525,000 after acquiring an additional 441 shares in the last quarter. Vicus Capital increased its stake in Intuitive Surgical by 25.1% in the 2nd quarter. Vicus Capital now owns 1,127 shares of the medical equipment provider’s stock worth $501,000 after acquiring an additional 226 shares during the last quarter. Finally, Burns J W & Co. Inc. NY increased its position in Intuitive Surgical by 23.3% in the second quarter. Burns J W & Co. Inc. NY now owns 9,037 shares of the medical equipment provider’s stock worth $4,020,000 after purchasing an additional 1,708 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $550.28.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.4 %

Shares of ISRG stock opened at $541.99 on Tuesday. The company has a market cap of $193.05 billion, a PE ratio of 87.14, a PEG ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $320.26 and a 12-month high of $556.23. The business’s fifty day simple moving average is $523.24 and its 200-day simple moving average is $480.55.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.